Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial...

  • Main
  • 2020 / 11
  • Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial...

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors

Delord, Jean-Pierre, Italiano, Antoine, Awada, Ahmad, Aftimos, Philippe, Houédé, Nadine, Lebbé, Céleste, Pages, Celine, Lesimple, Thierry, Dinulescu, Monica, Schellens, Jan H. M., Leijen, Suzanne,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Targeted Oncology
DOI:
10.1007/s11523-020-00768-0
Date:
November, 2020
File:
PDF, 733 KB
2020
Conversion to is in progress
Conversion to is failed